Escala Medical

The first non-surgical repair for Pelvic Organ Prolapse

Industry: Biohealth

Country: Israel


Approximately 50% of women over the age of 40 worldwide are affected by Pelvic Organ Prolapse (POP). Out of all cases, 89% seek treatment for early-stage prolapse symptoms. Despite the high prevalence and the progressive nature of POP, patients are currently unable to receive a repair solution until their condition worsens enough to require surgical intervention. However, surgical procedures for prolapse repair come with various side effects such as prolonged recovery, pelvic pain, and the potential for POP relapses.


Escala Medical has created a minimally invasive and incision-free repair intervention called Apyx specifically designed for early-stage POP. Apyx represents the first medical device aimed at treating early-stage prolapse, helping patients regain their quality of life and preventing further deterioration of the condition. The EIC project will focus on completing the development of Apyx, conducting clinical trials, and providing support for its scale-up and commercialization activities.